TY - JOUR
T1 - N-(levodopa) chitosan derivative based on click chemistry shows biological functionality in brain cells
AU - Ortega-Fimbres, Olimpia
AU - Montiel-Herrera, Marcelino
AU - García-Villa, Denisse
AU - Pérez-Delgado, Jonathan
AU - Monge-Sanchez, Diana
AU - Fernández-Quiroz, Daniel
AU - de la Re-Vega, Enrique
AU - Molina-Domínguez, Claudia
AU - Angulo-Molina, Aracely
AU - Castillo-Martín del Campo, Claudia
AU - Argüelles-Monal, Waldo
AU - Astiazaran-García, Humberto
AU - Preciado-Saldaña, Alejandra
AU - Domínguez-Ávila, Abraham
AU - González-Aguilar, Gustavo
N1 - Publisher Copyright:
© 2023 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023
Y1 - 2023
N2 - Objective: To develop N-(levodopa) chitosan derivatives through click chemistry to study their effect in brain cells. Significance: This study presents a proof-of-concept that macromolecules such as N-(Levodopa) chitosan derivatives traverse brain cell membranes and induce biomedical functionalities. Methods: Through click chemistry, we developed N-(levodopa) chitosan derivatives. They were physically and chemically characterized by FT-IR, 1H-NMR, TGA and Dynamic Light Scattering analyses. Solution and nanoparticles of N-(levodopa) chitosan derivatives were tested in primary cell cultures from the postnatal rat olfactory bulb, substantia nigra and corpus callosum. Ca2+ imaging and UPLC experiments were used to investigate if the biomaterial modulated the brain cell physiology. Results: N-(levodopa) chitosan derivatives induced intracellular Ca2+ responses in primary cell cultures of the rat brain. UPLC experiments indicated that levodopa attached to chitosan was converted into dopamine by brain cells. Conclusion: The present study shows that N-(levodopa) chitosan may be useful to develop new treatment strategies, which could serve as molecular reservoirs of biomedical drugs to treat degenerative disorders of the nervous system.
AB - Objective: To develop N-(levodopa) chitosan derivatives through click chemistry to study their effect in brain cells. Significance: This study presents a proof-of-concept that macromolecules such as N-(Levodopa) chitosan derivatives traverse brain cell membranes and induce biomedical functionalities. Methods: Through click chemistry, we developed N-(levodopa) chitosan derivatives. They were physically and chemically characterized by FT-IR, 1H-NMR, TGA and Dynamic Light Scattering analyses. Solution and nanoparticles of N-(levodopa) chitosan derivatives were tested in primary cell cultures from the postnatal rat olfactory bulb, substantia nigra and corpus callosum. Ca2+ imaging and UPLC experiments were used to investigate if the biomaterial modulated the brain cell physiology. Results: N-(levodopa) chitosan derivatives induced intracellular Ca2+ responses in primary cell cultures of the rat brain. UPLC experiments indicated that levodopa attached to chitosan was converted into dopamine by brain cells. Conclusion: The present study shows that N-(levodopa) chitosan may be useful to develop new treatment strategies, which could serve as molecular reservoirs of biomedical drugs to treat degenerative disorders of the nervous system.
KW - Biomaterials
KW - biogenic amines
KW - brain disorders
KW - calcium and cellular physiology
KW - click and green chemistry
KW - dementia
UR - http://www.scopus.com/inward/record.url?scp=85163021701&partnerID=8YFLogxK
U2 - 10.1080/03639045.2023.2224878
DO - 10.1080/03639045.2023.2224878
M3 - Artículo
C2 - 37310383
AN - SCOPUS:85163021701
SN - 0363-9045
VL - 49
SP - 439
EP - 447
JO - Drug Development and Industrial Pharmacy
JF - Drug Development and Industrial Pharmacy
IS - 7
ER -